
Description
Esberitox® N
Supporting the immune defence of the organism

ThujaeЕchinaceaBaptisiae
with active substances from the nature
Esberitox® N helps for:
- Prophylactics
- Faster recovery
- Reduced severity of the symptomatology
- Reduced frequency of recurrences
Application:
- Therapy of acute & chronic respiratory tract infections (of viral or bacterial origin)
-
Concomitant therapy foran antibiotic treatmentConcomitant therapy foran antibiotic treatment
- Preventive – before flu season or twice a year
- Bacterial skin infections
- Leucopoenia after radiation
- In parallel with cytostatic treatment
- Susceptibility to infections
Dosage:
breast-fed children:
3 х 10 drops or 3 х 1 tabl. daily
children under 6:
3 х 15 drops or 3 х 1-2 tabl. daily
children under 12:
3 х 25 drops or 3 х 2 tabl. daily
adults:
3 х 50 drops or 3 х 3 tabl. daily
Esberitox® N is product №1 in Germany for 2008 in the group of the immunomodulators!

Summary
For centuries, preparations from the purple coneflower have been used for the stimulation of the immune system against the common cold. Esberitox ® mono contains the aerial parts of the coneflower as standardized active substance.
In case of recurrent (frequent) respiratory tract infections the immunoresistance can be sensibly strengthened with this medicine.
Product Information of Esberitox ® mono Tablets
|
|
Dear patient! |
|
Active Substance: |
Dry extract of pressed purple coneflower juice |
|
Composition: |
1 tablet contains: |
|
Pharmaceutical Form and Content: |
Original package of 50 tablets (N2) |
|
Substance or Indication Group/ Mode of Action: |
Immunomodulator for the increase in the body's immunoresistance. |
|
Pharmaceutical Enterprise |
Schaper & Brummer GmbH & Co. KG, 38251 Salzgitter, Germany |
|
Indications: |
Supporting therapy of recurrent (frequently recurring) infections of the respiratory tract. |
|
Contraindications: |
When not to use Esberitox ® mono tablets: |
|
Interactions: |
Which other drugs influence the effect of Esberitox ® mono tablets? |
|
Dosage Directions, Route and Duration of Administration: |
The following information applies, unless you have received different instructions from your treating physician for the administration of Esberitox ® mono tablets. Please adhere to theses directions, as otherwise Esberitox ® mono tablets cannot work correctly! |
|
Side Effects : |
Which side effects can occur during the administration of Esberitox ® mono tablets? |
|
Warnings and Information Regarding Drug Stability: |
The expiration date of this package is imprinted on the side flap. Please do not use after this date. |
|
Status of the Information : |
April 2001 |
|
|
This drug is being marketed as per the German legal transition status regulations. The official investigation of pharmaceutical quality, effectiveness and safety has not been concluded yet. |
|
|
Keep drugs out of reach of children! |
|
Characteristics : |
Esberitox ® mono tablets contain active substances from the purple coneflower. These activate the body-own defense system (immune system) in humans and increase the resilience of the entire organism. Esberitox ® mono tablets can support overcoming infections of viral or bacterial origin. In case of viral respiratory tract infections the stabilization of the immune system with Esberitox ® mono tablets is particularly important, because duration and severity as well as the frequency of viral respiratory infections are influenced to a great extent by the capacity of the body-own defense system. |

